🔗 Share this article

While the US continues making historic changes to its vaccine recommendations, a particular individual has surfaced in a surprising turn: Dr. Tracy Beth Høeg, a Danish American physician and public health researcher who initially gained attention by questioning Covid vaccinations throughout the pandemic and has focused upon alleged deaths after COVID-19 vaccination in her short tenure at the FDA.

Proposed Overhauls to Childhood Vaccine Schedule

Public health authorities planned to reveal sweeping changes to the childhood vaccine schedule recently, bringing the US with Denmark’s national calendar, according to reports – a major change that would place the US at odds with a large portion of the international standard with little proof for public health gain. This reveal has been pushed back until the new year.

In place of the top vaccines chief, Dr. Høeg is scheduled to address the audience at the event. She was recently named interim head of the FDA’s CDER, the fifth appointee to lead the office this calendar year.

Consolidating Power at the Agency

The acting appointment could signify a strengthened alliance between the drug and vaccine divisions as Høeg and Prasad solidify control at the FDA – and it signals a greater focus upon reevaluating long-standing immunizations at the FDA.

The new acting director has frequently advocated for ending specific childhood immunization guidelines in the US in order to be more like Denmark, a country with nationalized medicine and a citizenry approximately the population of the state of Wisconsin.

In her initial comments, she has continued to focus on vaccines – usually the purview of Dr. Prasad, chief of the FDA’s vaccine center – rather than medication approval.

Doubts Over Expertise

The appointee has no apparent track record in pharmaceutical research, oversight or management, which has been typical for previous directors of the Center for Biologics Evaluation and Research. She has served at the FDA as a key advisor to the agency head and the vaccine center since March.

“She doesn’t seem to have the requisite experience” for overseeing the CDER, said Dr. Jonathan Howard. “She lacks experience running a clinical trial. She is not versed in managing a major agency. She lacks background in pharmaceutical oversight.”

Former heads of the center would “be deeply familiar with laws and regulations and the underlying principles of medication creation”, said a former acting FDA commissioner. “Objectively, she lacks the type of experience that previous people who headed the center have had.”

CDER has an enormous workload at the agency, the former commissioner stated.

“Many people just pays attention on the novel medication approvals, but the off-patent medication office approves thousands of generic medications. There is also a biosimilars program, non-prescription drug unit and other areas, and every single one have to be looked after,” Dr. Woodcock noted. “The thing you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Furthermore, a substantial leadership aspect to the position, which supervises in excess of 5,000 personnel. “It is a massive administrative position, if you do it right,” she added.

Official Statement and Controversial Initiatives

Regarding questions about Dr. Høeg's credentials and whether this assignment indicates more teamwork among regulatory chiefs on vaccines, a press secretary stated that the “inquiries are based on inaccurate premises”.

“Her experience is consistent with the responsibilities of her position,” the spokesperson said, citing the period Høeg spent counseling the agency head on “pharmaceutical safety and approval science, including computerized risk analysis and immunization monitoring”.

In her interim role, Dr. Høeg takes over the agency head's controversial fast-track approval initiative, a disputed expedited drug-approval program that allegedly troubled her preceding directors. “By what process are these drugs being picked for this fast-track system? Who takes the calls?” Dr. Howard said. “There’s a lot of secrecy occurring at the FDA right now.”

Broadly speaking, he remarked, “the FDA seems to be moving towards more relaxed rules of all drugs, aside from shots.”

Documented History on Vaccines

Regarding vaccines, Dr. Høeg has a more established, if concerning, past, some experts said. She authored a study using unverified crowd-sourced reports to assess the frequency of heart inflammation following Covid vaccination. She consulted for the state of Florida surgeon general Dr. Joseph Ladapo, who reportedly have modified findings to suggest COVID-19 vaccines are riskier than they are.

Part of her “policy goals” for the current government included changing rules for recently developed shots and halting “non-essential” immunizations, she remarked after the election on a audio program. At the FDA, Dr. Høeg has allegedly proposed barring teenage boys from receiving Covid vaccines.

“She’s an complete dogmatist who begins with her beliefs and works backwards to fit the evidence in a extremely misleading, untruthful fashion,” Howard stated.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg joined fellow contrarians, {like|